- Country: Brazil
- Summary: Medicines Judicial Demand (restricted)
- BRT Ref No: 72765026
- Deadline: 21 Oct 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PE 142/2022
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Drugs Judicial Demand (Restricted)
Expected execution deadline: 10 days
Session Opening: 10/21/2022 Time: 0900 AM
Composition of items:
Sequence - Summary Description - Unit of Measurement - Quantity
1 - 4482824 - Canagliflozine 300mg - 01 - Unit - 1080
2 - 2216728 - AMISSULPRIDE 50mg - 01 - Unit - 240
3 - 5826870 - BREXPIPRAZOL 2mg - 01 - Unit - 180
4 - 6114768 - PREGABALINA 25mg - 01 - Unit - 180
5 - 1539248 - Venlafaxine 150mg - 01 - Unit - 480
6 - 5438977 - SEMAGLUTIDO 1mg/1.5ml Sol.inj. 1.5ml - 01 - Unit - 12
7 - 824674 - Amissulprida 200mg - 01 - Unit - 240
8 - 2347385 - Meclizine 25mg - 01 - Unit - 360
9 - 691453 - MIRTAZAPINA 30mg - 01 - Unit - 240 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicines Judicial Demand (restricted) - Brazil Tender
The COORDINATION OF HEALTH REGIONS, a Government sector organization in Brazil, has announced a new tender for Medicines Judicial Demand (restricted). This tender is published on BrazilTenders under BRT Ref No: 72765026 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-10-21.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
